Funding for this research was provided by:
Università degli Studi di Milano
Received: 15 February 2023
Accepted: 12 April 2023
First Online: 18 April 2023
: The study protocol was approved by the research ethics board of the Ospedale Maggiore Policlinico (Ref. no. 930_2022). Consent for publication of data was obtained from all patients.
: DS, ES, SC, AL, and AG report no conflicts of interest. GG reports receiving personal fees from Getinge, Biotest, Pfizer, Dräger, and Fisher and Paykel. TM reports receiving personal fees from Fisher and Paykel, Dräger, Mindray, and B. Braun.